Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
91.3566062
Mar.Cap(Rs.Cr)
35,635.41
P/E
56.06
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Profit And Loss
ParticularsMar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
Mar 2018
(Rs.Cr)
INCOME :      
Sales Turnover 3216.343217.512920.483224.683128.532895.88
Excise Duty0.000.000.000.000.0024.19
Net Sales3216.343217.512920.483224.683128.532871.69
Other Income 114.961423.27217.71624.37149.5671.32
Stock Adjustments -67.25-13.8326.1235.43-25.5757.94
Total Income3264.054626.953164.313884.483252.523000.95
EXPENDITURE :      
Raw Materials 1182.781281.911275.491343.301327.961298.69
Power & Fuel Cost29.6027.8326.0833.3627.9426.44
Employee Cost 594.99610.23616.16628.55537.20523.40
Other Manufacturing Expenses 99.05120.14110.59107.88115.19110.55
Selling & Administrative Expenses 370.30343.57242.00376.68381.32357.82
Miscellaneous Expenses 84.3285.69287.75983.19150.08104.29
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure2361.042469.382558.073472.962539.682421.18
Operating Profit903.012157.57606.24411.52712.85579.76
Interest 1.811.993.536.340.550.19
Gross Profit901.202155.58602.71405.18712.30579.57
Depreciation65.7768.1978.6082.6848.5937.99
Profit Before Tax835.432087.39524.11322.50663.71541.58
Tax246.05407.36158.67260.17192.82204.34
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-18.37-10.497.87-47.7245.52-14.74
Reported Net Profit607.751690.53357.57110.05425.36351.99
Extraordinary Items 21.0511.18-117.79-87.094.049.57
Adjusted Net Profit586.701679.35475.36197.14421.32342.42
Adjustment below Net Profit -17.08-11.050.00-73.62-64.12-51.73
P & L Balance brought forward1745.02562.71882.771177.991113.211067.06
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 1524.66508.22677.62338.81296.46254.11
P & L Balance carried down811.031733.98562.71875.621177.991113.21
Dividend0.000.000.000.000.00296.46
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %320.00900.00300.00400.00200.00350.00
Dividend Per Share(Rs)32.0090.0030.0040.0020.0035.00
Earnings Per Share-Unit Curr35.8899.7921.116.5025.1141.56
Earnings Per Share(Adj)-Unit Curr35.8899.7921.116.5025.1120.78
Book Value-Unit Curr103.48158.0688.37108.62126.47245.56
Book Value(Adj)-Unit Curr103.48158.0688.37108.62126.47122.78
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)